Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Mary Ellen Csuka MD

Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Rheumatology
Program: Administration

View Curriculum Vitae

Publications (47)

  • Daniel J McCarty, MD: A Giant of Rheumatology. (Rosenthal AK, Csuka ME, Halverson P) Rheum Dis Clin North Am 2024 Feb;50(1):15-23 PMID: 37973282 SCOPUS ID: 2-s2.0-85169505673 11/17/2023    
  • Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy. (Shah A, Storek J, Woolson R, Pinckney A, Keyes-Elstein L, Wallace PK, Sempowski GD, McSweeney P, Mayes MD, Crofford L, Csuka ME, Phillips K, Khanna D, Simms R, Ballen K, LeClercq S, Clair WS, Nixon AB, Nash R, Wener M, Brasington R, Silver R, Griffith LM, Furst DE, Goldmuntz E, Sullivan KM) Rheumatology (Oxford) 2022 Oct 06;61(10):4155-4162 PMID: 35108379 PMCID: PMC9536786 SCOPUS ID: 2-s2.0-85131873826 02/03/2022       8 Citations
  • Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data. (Keyes-Elstein L, Pinckney A, Goldmuntz E, Welch B, Franks JM, Martyanov V, Wood TA, Crofford L, Mayes M, McSweeney P, Nash R, Georges G, Csuka ME, Simms R, Furst D, Khanna D, Clair EWS, Whitfield ML, Sullivan KM) Arthritis Care Res (Hoboken) 2023 Feb;75(2):307-316 PMID: 34533286 PMCID: PMC8926930 SCOPUS ID: 2-s2.0-85143216083 09/18/2021       9 Citations
  • Determinants of low bone mineral density in people with multiple sclerosis: Role of physical activity. (Cleland BT, Papanek P, Ingraham BA, Harkins A, Garnier-Villarreal M, Woo D, Csuka ME, V Ng A) Mult Scler Relat Disord 2020 Feb;38:101864 PMID: 31801106 SCOPUS ID: 2-s2.0-85075743778 12/05/2019       12 Citations
  • Efficacy of Osteoporosis Prevention Smartphone App. (Ryan P, Brown RL, Csuka ME, Papanek P) Nurs Res 2020;69(1):31-41 PMID: 31568199 PMCID: PMC7105101 SCOPUS ID: 2-s2.0-85076449244 10/01/2019       11 Citations
  • Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry. (Hsu VM, Chung L, Hummers LK, Shah A, Simms R, Bolster M, Hant FN, Silver RM, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Saketkoo LA, Salazar CR, Steen VD) J Rheumatol 2019 Feb;46(2):176-183 PMID: 30275260 SCOPUS ID: 2-s2.0-85060958271 10/03/2018       28 Citations
  • Background and method of the Striving to be Strong study a RCT testing the efficacy of a m-health self-management intervention. (Ryan P, Papanek P, Csuka ME, Brown ME, Hopkins S, Lynch S, Scheer V, Schlidt A, Yan K, Simpson P, Hoffman R, Striving to be Strong Team) Contemp Clin Trials 2018 Aug;71:80-87 PMID: 29894865 SCOPUS ID: 2-s2.0-85048278984 06/13/2018       14 Citations
  • Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma. (Sullivan KM, Goldmuntz EA, Keyes-Elstein L, McSweeney PA, Pinckney A, Welch B, Mayes MD, Nash RA, Crofford LJ, Eggleston B, Castina S, Griffith LM, Goldstein JS, Wallace D, Craciunescu O, Khanna D, Folz RJ, Goldin J, St Clair EW, Seibold JR, Phillips K, Mineishi S, Simms RW, Ballen K, Wener MH, Georges GE, Heimfeld S, Hosing C, Forman S, Kafaja S, Silver RM, Griffing L, Storek J, LeClercq S, Brasington R, Csuka ME, Bredeson C, Keever-Taylor C, Domsic RT, Kahaleh MB, Medsger T, Furst DE, SCOT Study Investigators) N Engl J Med 2018 Jan 04;378(1):35-47 PMID: 29298160 PMCID: PMC5846574 SCOPUS ID: 2-s2.0-85040338916 01/04/2018       509 Citations
  • Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. (Chung L, Fairchild RM, Furst DE, Li S, Alkassab F, Bolster MB, Csuka ME, Derk CT, Domsic RT, Fischer A, Frech TM, Gomberg-Maitland M, Gordon JK, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TAJ, Molitor JA, Preston IR, Schiopu E, Shapiro L, Hant F, Silver R, Simms R, Varga J, Steen VD, Zamanian RT) Clin Exp Rheumatol 2017;35 Suppl 106(4):106-113 PMID: 27908301 SCOPUS ID: 2-s2.0-85031692578 12/03/2016       18 Citations
  • The Recurrence of Digital Ulcers in Patients with Systemic Sclerosis after Discontinuation of Oral Treprostinil. (Shah AA, Schiopu E, Chatterjee S, Csuka ME, Frech T, Goldberg A, Spiera R, Peng SL, McBride RJ, Cleveland JM, Steen V) J Rheumatol 2016 Sep;43(9):1665-71 PMID: 27307535 SCOPUS ID: 2-s2.0-84984984880 06/17/2016       20 Citations
  • Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. (Fischer A, Swigris JJ, Bolster MB, Chung L, Csuka ME, Domsic R, Frech T, Hinchcliff M, Hsu V, Hummers LK, Gomberg-Maitland M, Mathai SC, Simms R, Steen VD) Clin Exp Rheumatol 2014;32(6 Suppl 86):S-109-14 PMID: 25372796 SCOPUS ID: 2-s2.0-85006282765 11/06/2014       31 Citations
  • Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study. (Hsu VM, Chung L, Hummers LK, Wigley F, Simms R, Bolster M, Silver R, Fischer A, Hinchcliff ME, Varga J, Goldberg AZ, Derk CT, Schiopu E, Khanna D, Shapiro LS, Domsic RT, Medsger T, Mayes MD, Furst D, Csuka ME, Molitor JA, Alkassab F, Steen VD) Semin Arthritis Rheum 2014 Aug;44(1):55-62 PMID: 24709277 SCOPUS ID: 2-s2.0-84905255169 04/09/2014       79 Citations
  • 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. (van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE) Arthritis Rheum 2013 Nov;65(11):2737-47 PMID: 24122180 PMCID: PMC3930146 SCOPUS ID: 2-s2.0-84886777196 10/15/2013       2767 Citations
  • Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry. (Chung L, Domsic RT, Lingala B, Alkassab F, Bolster M, Csuka ME, Derk C, Fischer A, Frech T, Furst DE, Gomberg-Maitland M, Hinchcliff M, Hsu V, Hummers LK, Khanna D, Medsger TA Jr, Molitor JA, Preston IR, Schiopu E, Shapiro L, Silver R, Simms R, Varga J, Gordon JK, Steen VD) Arthritis Care Res (Hoboken) 2014 Mar;66(3):489-95 PMID: 23983198 PMCID: PMC11936387 SCOPUS ID: 2-s2.0-84896692199 08/29/2013       144 Citations
  • Computer-based intervention to enhance self-management of calcium and vitamin D intake in women. (Ryan P, Maierle D, Csuka ME, Thomson A, Szabo A) West J Nurs Res 2013 Sep;35(8):986-1010 PMID: 23539320 PMCID: PMC4545626 SCOPUS ID: 2-s2.0-84880784091 03/30/2013       23 Citations
  • Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial. (Hung EW, Mayes MD, Sharif R, Assassi S, Machicao VI, Hosing C, St Clair EW, Furst DE, Khanna D, Forman S, Mineishi S, Phillips K, Seibold JR, Bredeson C, Csuka ME, Nash RA, Wener MH, Simms R, Ballen K, Leclercq S, Storek J, Goldmuntz E, Welch B, Keyes-Elstein L, Castina S, Crofford LJ, Mcsweeney P, Sullivan KM) J Rheumatol 2013 Apr;40(4):455-60 PMID: 23418384 PMCID: PMC3652008 SCOPUS ID: 2-s2.0-84875848230 02/19/2013       64 Citations
  • Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. (Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C, Domsic R, Fischer A, Frech T, Goldberg A, Hinchcliff M, Hsu V, Hummers L, Schiopu E, Mayes MD, McLaughlin V, Molitor J, Naz N, Furst DE, Maranian P, Steen V, Khanna D) Ann Rheum Dis 2012 Aug;71(8):1335-42 PMID: 22307943 PMCID: PMC3398226 SCOPUS ID: 2-s2.0-84863812040 02/07/2012       84 Citations
  • Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise. (Fransen J, Johnson SR, van den Hoogen F, Baron M, Allanore Y, Carreira PE, Czirják L, Denton CP, Distler O, Furst DE, Gabrielli A, Herrick A, Inanc M, Kahaleh B, Kowal-Bielecka O, Medsger TA Jr, Mueller-Ladner U, Riemekasten G, Sierakowski S, Valentini G, Veale D, Vonk MC, Walker U, Chung L, Clements PJ, Collier DH, Csuka ME, Jimenez S, Merkel PA, Seibold JR, Silver R, Steen V, Tyndall A, Matucci-Cerinic M, Pope JE, Khanna D) Arthritis Care Res (Hoboken) 2012 Mar;64(3):351-7 PMID: 22052558 PMCID: PMC3288452 SCOPUS ID: 2-s2.0-84859844674 11/05/2011       56 Citations
  • Generalized morphea after breast cancer radiation therapy. (Kushi J, Csuka ME) Case Rep Rheumatol 2011;2011:951948 PMID: 22937449 PMCID: PMC3420376 01/01/2011    
  • Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. (Xu H, Zaidi M, Struve J, Jones DW, Krolikowski JG, Nandedkar S, Lohr NL, Gadicherla A, Pagel PS, Csuka ME, Pritchard KA, Weihrauch D) Am J Physiol Cell Physiol 2011 Mar;300(3):C550-6 PMID: 21160034 PMCID: PMC3063974 SCOPUS ID: 2-s2.0-79952158516 12/17/2010       42 Citations
  • Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. (Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR, Relaxin Investigators and the Scleroderma Clinical Trials Consortium) Arthritis Rheum 2009 Apr;60(4):1102-11 PMID: 19333948 PMCID: PMC3711466 SCOPUS ID: 2-s2.0-65249109216 04/01/2009       122 Citations
  • MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. (Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N, Steen V, Martin RW, Smith E, Mayes M, Simms R, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM) Arthritis Rheum 2009 Mar;60(3):870-7 PMID: 19248104 SCOPUS ID: 2-s2.0-61649118817 02/28/2009       100 Citations
  • Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice. (Weihrauch D, Xu H, Shi Y, Wang J, Brien J, Jones DW, Kaul S, Komorowski RA, Csuka ME, Oldham KT, Pritchard KA) Am J Physiol Heart Circ Physiol 2007 Sep;293(3):H1432-41 PMID: 17496220 SCOPUS ID: 2-s2.0-34548433520 05/15/2007       71 Citations
  • Outcome measurements in scleroderma: results from a delphi exercise. (Gazi H, Pope JE, Clements P, Medsger TA, Martin RW, Merkel PA, Kahaleh B, Wollheim FA, Baron M, Csuka ME, Emery P, Belch JF, Hayat S, Lally EV, Korn JH, Czirjak L, Herrick A, Voskuyl AE, Bruehlmann P, Inanc M, Furst DE, Black C, Ellman MH, Moreland LW, Rothfield NF, Hsu V, Mayes M, McKown KM, Krieg T, Siebold JR) J Rheumatol 2007 Mar;34(3):501-9 PMID: 17299843 SCOPUS ID: 2-s2.0-33847621190 02/15/2007       57 Citations
  • Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature. (Jaovisidha K, Csuka ME, Almagro UA, Soergel KH) Semin Arthritis Rheum 2005 Feb;34(4):689-702 PMID: 15692963 SCOPUS ID: 2-s2.0-13244262707 02/05/2005       73 Citations
  • Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial. (Mayes MD, O'Donnell D, Rothfield NF, Csuka ME) Arthritis Rheum 2004 Feb;50(2):553-7 PMID: 14872498 SCOPUS ID: 2-s2.0-1042290310 02/12/2004       29 Citations
  • Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy. (Prajapati DN, Knox JF, Emmons J, Saeian K, Csuka ME, Binion DG) J Clin Gastroenterol 2003 Aug;37(2):125-8 PMID: 12869881 SCOPUS ID: 2-s2.0-0038115119 07/19/2003       40 Citations
  • Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. (Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium) Arthritis Rheum 2002 Sep;46(9):2410-20 PMID: 12355489 SCOPUS ID: 2-s2.0-0036746069 10/02/2002       318 Citations
  • Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. (Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannigan J, Harkonen WS, Sanders ME) Ann Intern Med 2000 Jun 06;132(11):871-9 PMID: 10836913 SCOPUS ID: 2-s2.0-0034612234 06/03/2000       248 Citations
  • Polysynovitis associated with acute Epstein-Barr virus infection. (McCarty DJ, Csuka ME) J Rheumatol 1998 Oct;25(10):2039-40 PMID: 9779871 SCOPUS ID: 2-s2.0-0031783464 10/21/1998       3 Citations
  • Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. (Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR) Arthritis Rheum 1998 Apr;41(4):670-7 PMID: 9550476 SCOPUS ID: 2-s2.0-0031947367 04/29/1998       180 Citations
  • Concurrent gout and Mycobacterium tuberculosis arthritis. (Lorenzo JP, Csuka ME, Derfus BA, Gotoff RA, McCarthy GM) J Rheumatol 1997 Jan;24(1):184-6 PMID: 9002033 SCOPUS ID: 2-s2.0-0031035822 01/01/1997       17 Citations
  • Resolution of a soft-tissue sarcoma in a patient with rheumatoid arthritis after discontinuation of azathioprine therapy. (Csuka ME, Hanson GA) Arch Intern Med 1996 Jul 22;156(14):1573-6 PMID: 8687266 SCOPUS ID: 2-s2.0-0030016046 07/22/1996       5 Citations
  • The prevalence of sexual abuse in women with fibromyalgia. (Taylor ML, Trotter DR, Csuka ME) Arthritis Rheum 1995 Feb;38(2):229-34 PMID: 7848313 SCOPUS ID: 2-s2.0-0028877788 02/01/1995       140 Citations
  • Activity of oxidative routes of metabolism of debrisoquin, mephenytoin, and dapsone is unrelated to the pathogenesis of vinyl chloride-induced disease. (Black C, May G, Csuka ME, Lupoli S, Wilkinson GR, Branch RA) Clin Pharmacol Ther 1992 Dec;52(6):659-67 PMID: 1458774 SCOPUS ID: 2-s2.0-0026715612 12/01/1992       8 Citations
  • Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. (Derfus BA, Csuka ME, Carrera GF, Hanson GA, Smith RE) J Rheumatol 1991 May;18(5):738-42 PMID: 1865422 SCOPUS ID: 2-s2.0-0025899228 05/01/1991       4 Citations
  • Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin, and mephenytoin. (May DG, Black CM, Olsen NJ, Csuka ME, Tanner SB, Bellino L, Porter JA, Wilkinson GR, Branch RA) Clin Pharmacol Ther 1990 Sep;48(3):286-95 PMID: 2401127 SCOPUS ID: 2-s2.0-0025162357 09/01/1990       43 Citations
  • Aspirin and the treatment of rheumatoid arthritis. (Csuka ME, McCarty DJ) Rheum Dis Clin North Am 1989 Aug;15(3):439-54 PMID: 2672131 SCOPUS ID: 2-s2.0-0024360263 08/01/1989       12 Citations
  • Infusion of iloprost, a prostacyclin analogue, for treatment of Raynaud's phenomenon in systemic sclerosis. (McHugh NJ, Csuka M, Watson H, Belcher G, Amadi A, Ring EF, Black CM, Maddison PJ) Ann Rheum Dis 1988 Jan;47(1):43-7 PMID: 2449871 PMCID: PMC1003442 SCOPUS ID: 2-s2.0-0023870044 01/01/1988       98 Citations
  • Aspirin in the treatment of chronic inflammatory arthritis. (McCarty D, Csuka ME) JAMA 1987 Mar 13;257(10):1331 PMID: 3820440 SCOPUS ID: 2-s2.0-0023094229 03/13/1987       3 Citations
  • Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. (Csuka M, Brewer BJ, Lynch KL, McCarty DJ) J Rheumatol 1987 Feb;14(1):165-70 PMID: 3106631 SCOPUS ID: 2-s2.0-0023091190 02/01/1987       28 Citations
  • Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. (Csuka M, Carrera GF, McCarty DJ) JAMA 1986 May 02;255(17):2315-9 PMID: 3959321 SCOPUS ID: 2-s2.0-0022571745 05/02/1986       101 Citations
  • Gold induced aplastic anemia. Complete response to corticosteroids, plasmapheresis, and N-acetylcysteine infusion. (Hansen RM, Csuka ME, McCarty DJ, Saryan LA) J Rheumatol 1985 Aug;12(4):794-7 PMID: 4057204 SCOPUS ID: 2-s2.0-0021965931 08/01/1985       17 Citations
  • Simple method for measurement of lower extremity muscle strength. (Csuka M, McCarty DJ) Am J Med 1985 Jan;78(1):77-81 PMID: 3966492 SCOPUS ID: 2-s2.0-0021906966 01/01/1985       739 Citations
  • Transient hypothermia after corticosteroid treatment of subacute cutaneous lupus erythematosus. (Csuka ME, McCarty DJ) J Rheumatol 1984 Feb;11(1):112-3 PMID: 6699827 SCOPUS ID: 2-s2.0-0021383483 02/01/1984       7 Citations
  • Interpretation of laboratory results in the elderly. 1. A clinician's guide to hematologic and hepatorenal function tests. (Gambert SR, Csuka ME, Duthie EH Jr, Tiegs R) Postgrad Med 1982 Sep;72(3):147-52 PMID: 7122336 SCOPUS ID: 2-s2.0-0020385067 09/01/1982       8 Citations
  • Erythromycin ethylsuccinate hepatotoxicity. (Sullivan D, Csuka ME, Blanchard B) JAMA 1980 Mar 14;243(10):1074 PMID: 6965509 SCOPUS ID: 2-s2.0-0018842327 03/14/1980       23 Citations
    • Last update: 04/16/2025